Literature DB >> 8648727

The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein.

F He1, W S Blair, J Fukushima, B R Cullen.   

Abstract

The Bel-1 transcriptional transactivator encoded by human foamy virus (HFV) can efficiently activate gene expression directed by both the HFV long terminal repeat (LTR) and internal (Int) promoter elements. By DNA footprinting and gel retardation analysis, we demonstrate that Bel-1 can specifically bind to discrete sites in both the LTR and Int promoter elements in vitro. However, transactivation of the HFV LTR by Bel-1 was observed to require not only the promoter-proximal Bel-1 binding site identified in vitro but also additional promoter-distal sequences. These data suggest that Bel-1 binding is necessary but not sufficient for efficient transactivation of Bel-1-responsive promoters in mammalian cells and therefore raise the possibility that Bel-1 function may require the action of a cellular DNA binding protein(s). Importantly, these data demonstrate that Bel-1 is unique among retroviral regulatory proteins in being a sequence-specific DNA binding protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648727      PMCID: PMC190268     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.

Authors:  M H Malim; B R Cullen
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  Opposing regulatory functions of positive and negative elements in UASG control transcription of the yeast GAL genes.

Authors:  R L Finley; S Chen; J Ma; P Byrne; R W West
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 3.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

4.  How different eukaryotic transcriptional activators can cooperate promiscuously.

Authors:  Y S Lin; M Carey; M Ptashne; M R Green
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

5.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

6.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression.

Authors:  S J Triezenberg; R C Kingsbury; S L McKnight
Journal:  Genes Dev       Date:  1988-06       Impact factor: 11.361

7.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

Authors:  J Berger; J Hauber; R Hauber; R Geiger; B R Cullen
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

8.  The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region.

Authors:  A Rethwilm; O Erlwein; G Baunach; B Maurer; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter.

Authors:  J X Zou; P A Luciw
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae.

Authors:  J Mellor; M J Dobson; N A Roberts; M F Tuite; J S Emtage; S White; P A Lowe; T Patel; A J Kingsman; S M Kingsman
Journal:  Gene       Date:  1983-09       Impact factor: 3.688

View more
  27 in total

Review 1.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Human foamy virus bel1 sequence in patients with autoimmune rheumatic diseases.

Authors:  Kuang-Hui Sun; Hsiao-Yi Lin; Lee-Wen Chen; Hsiao-Yun Tai; Mei-Lin Lin; Chi-Kuang Feng; Jung-Sung Sung; Hsin-Fu Liu; Wu-Tse Liu
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

4.  Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing.

Authors:  D Lindemann; A Rethwilm
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  Foamy viruses are unconventional retroviruses.

Authors:  M L Linial
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

7.  Intra- and intercellular trafficking of the foamy virus auxiliary bet protein.

Authors:  Charles-Henri Lecellier; Wim Vermeulen; Françoise Bachelerie; Marie-Lou Giron; Ali Saïb
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1.

Authors:  Y Kang; B R Cullen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Further characterization of equine foamy virus reveals unusual features among the foamy viruses.

Authors:  Charles-Henri Lecellier; Manuel Neves; Marie-Lou Giron; Joelle Tobaly-Tapiero; Ali Saïb
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.